Codexis (CDXS) Shares Outstanding (Diluted Average) (2014 - 2026)

Codexis (CDXS) recorded quarterly Shares Outstanding (Diluted Average) of $90.8 million in Q1 2026, up 4.16% quarter-over-quarter from $87.1 million in Q4 2025, and up 10.14% on a YoY basis from $82.4 million in Q1 2025.

Codexis (CDXS) Shares Outstanding (Diluted Average) (2014 - 2026) Analysis & Trends

Codexis' Shares Outstanding (Diluted Average) history runs 13 years deep, the most recent figure standing at $90.8 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 10.14% year-over-year to $90.8 million; the TTM figure through Mar 2026 stood at $90.8 million (up 10.14% YoY), while the FY2025 annual figure was $87.1 million, up 18.71% from the prior year.
  • Shares Outstanding (Diluted Average) was $90.8 million for Q1 2026 at Codexis, up from $87.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $90.8 million in Q1 2026 to a low of $65.1 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $73.4 million across 5 years, with a median of $69.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) declined 3.65% in 2022, then grew 21.78% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $65.3 million in 2022, then gained by 4.27% to $68.1 million in 2023, then grew by 7.75% to $73.4 million in 2024, then grew by 18.71% to $87.1 million in 2025, then increased by 4.16% to $90.8 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $90.8 million (Q1 2026), $87.1 million (Q4 2025), and $86.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 256.30 Mn
9 Abivax 95.45 Bn 95.45 Bn - 92.44 Mn
10 Codexis 226.01 Mn 160.87 Mn 13.18 Mn 90.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.77 Mn
Dec 31, 2025 87.14 Mn
Sep 30, 2025 86.05 Mn
Jun 30, 2025 85.39 Mn
Mar 31, 2025 82.41 Mn
Dec 31, 2024 73.41 Mn
Sep 30, 2024 72.03 Mn
Jun 30, 2024 70.12 Mn
Mar 31, 2024 69.85 Mn
Dec 31, 2023 68.13 Mn
Sep 30, 2023 67.67 Mn
Jun 30, 2023 67.57 Mn
Mar 31, 2023 65.93 Mn
Dec 31, 2022 65.34 Mn
Sep 30, 2022 65.27 Mn
Jun 30, 2022 65.29 Mn
Mar 31, 2022 65.10 Mn
Dec 31, 2021 64.57 Mn
Sep 30, 2021 67.74 Mn
Jun 30, 2021 64.43 Mn